Models of hepatic elimination: comparison of stochastic models to describe residence time distributions and to predict the influence of drug distribution, enzyme heterogeneity, and systemic recycling on hepatic elimination
- PMID: 3373419
- DOI: 10.1007/BF01061862
Models of hepatic elimination: comparison of stochastic models to describe residence time distributions and to predict the influence of drug distribution, enzyme heterogeneity, and systemic recycling on hepatic elimination
Abstract
The residence time distribution of noneliminated solutes in the liver can be represented by a variety of stochastic models. The dispersion model (closed and mixed boundary conditions), gamma distribution, log normal distribution and normal distribution models were used to describe output concentration-time profiles after bolus injections into the liver of labeled erythrocytes and albumin. The dispersion model and log normal distribution model provide the best representation of the data and give similar estimates of relative dispersion and availability for varying hepatocellular enzyme activity. The availability of solutes eliminated from the liver by first-order kinetics is determined by the residence time distribution of the solute in the liver and not on events occurring in the liver when a uniform enzyme distribution is assumed. Both enzyme heterogeneity (axial or transverse) and hepatocyte permeability may affect solute availability. A more complex model accounting for enzyme distribution and the micromixing of solute within the liver is required for solutes undergoing saturable kinetics.
Similar articles
-
A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations.J Pharmacokinet Biopharm. 1986 Jun;14(3):227-60. doi: 10.1007/BF01106706. J Pharmacokinet Biopharm. 1986. PMID: 3783446
-
Modeling of hepatic elimination and organ distribution kinetics with the extended convection-dispersion model.J Pharmacokinet Biopharm. 1999 Aug;27(4):343-82. doi: 10.1023/a:1020992421184. J Pharmacokinet Biopharm. 1999. PMID: 10826128
-
Residence time distribution of diazepam in the isolated perfused rat liver. Analysis with the axial dispersion model.Rev Esp Fisiol. 1992 Dec;48(4):221-9. Rev Esp Fisiol. 1992. PMID: 1302891
-
Hepatic clearance models: comparison of the dispersion and Goresky models in outflow profiles from multiple indicator dilution rat liver studies.Drug Metab Dispos. 1998 May;26(5):465-75. Drug Metab Dispos. 1998. PMID: 9571228 Review.
-
A new model-independent physiological approach to study hepatic drug clearance and its applications.Int J Clin Pharmacol Ther Toxicol. 1984 Nov;22(11):577-90. Int J Clin Pharmacol Ther Toxicol. 1984. PMID: 6389376 Review.
Cited by
-
Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.Pharm Res. 2012 Jun;29(6):1658-69. doi: 10.1007/s11095-012-0690-z. Pharm Res. 2012. PMID: 22302523
-
Residence time distributions of solutes in the perfused rat liver using a dispersion model of hepatic elimination: 1. Effect of changes in perfusate flow and albumin concentration on sucrose and taurocholate.J Pharmacokinet Biopharm. 1990 Jun;18(3):209-34. doi: 10.1007/BF01062200. J Pharmacokinet Biopharm. 1990. PMID: 2116519
-
Generalized stochastic compartmental models with Erlang transit times.J Pharmacokinet Biopharm. 1990 Dec;18(6):589-607. doi: 10.1007/BF01073940. J Pharmacokinet Biopharm. 1990. PMID: 2280350
-
Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies.Br J Cancer. 2001 Jul 20;85(2):157-65. doi: 10.1054/bjoc.2001.1902. Br J Cancer. 2001. PMID: 11461070 Free PMC article. Clinical Trial.
-
A compartmental model of hepatic disposition kinetics: 1. Model development and application to linear kinetics.J Pharmacokinet Pharmacodyn. 2002 Apr;29(2):131-56. doi: 10.1023/a:1019703607647. J Pharmacokinet Pharmacodyn. 2002. PMID: 12361240